Related Experiment Video

Updated: Aug 9, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Natural history of postoperative heart block in congenital heart disease: implications for pacing intervention

Gil J Gross1, Christine C Chiu, Robert M Hamilton

  • 1Cardiology Division, Hospital for Sick Children, Toronto, Ontario, Canada. ggross@sickkids.ca

Heart Rhythm
|May 2, 2006
PubMed

Insights

Permanent pacemaker implantation after surgery for congenital heart disease is often based on transient heart block duration. However, other factors may influence long-term outcomes, suggesting a need to refine current pacing guidelines.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Congenital heart disease (CHD) management has advanced significantly.
  • Atrioventricular conduction block remains a complication in 1-3% of CHD surgeries.
  • Permanent postoperative heart block carries a high mortality risk (28-100%) if untreated with a pacemaker.

Purpose of the Study:

  • To evaluate the current criteria for permanent pacemaker implantation following CHD surgery.
  • To explore the role of factors beyond transient heart block duration in long-term patient outcomes.
  • To suggest a reconsideration of existing pacing guidelines for postoperative heart block.

Main Methods:

  • Review of natural history data for patients with postoperative heart block.
  • Analysis of factors influencing mortality and morbidity in transient heart block cases.
  • Assessment of current professional pacemaker implantation guidelines.

Main Results:

  • Postoperative heart block is often transient, resolving within 10 days.
  • Guideline-based pacemaker implantation relies heavily on the duration of heart block.
  • Emerging data indicate late mortality/morbidity in patients with transient heart block, suggesting other injury factors.

Conclusions:

  • Current pacemaker implantation guidelines for postoperative heart block may be insufficient.
  • Residual conduction system injury might contribute to late adverse events.
  • Refined pacing indications are necessary given improved CHD survival and pacing technology.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...